| 000 | 01201 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517043615.0 | ||
| 264 | 0 | _c20160926 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1744-7631 | ||
| 024 | 7 |
_a10.1517/14728222.2015.1073713 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGautier, Thomas | |
| 245 | 0 | 0 |
_aThe potential of cholesteryl ester transfer protein as a therapeutic target. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic targets _c2016 |
||
| 300 |
_a47-59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtherosclerosis _xetiology |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
| 650 | 0 | 4 |
_aCholesterol Ester Transfer Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aMasson, David | |
| 700 | 1 | _aLagrost, Laurent | |
| 773 | 0 |
_tExpert opinion on therapeutic targets _gvol. 20 _gno. 1 _gp. 47-59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728222.2015.1073713 _zAvailable from publisher's website |
| 999 |
_c25110507 _d25110507 |
||